Loading...
Loading...
By MBN Staff - Fri, 04/25/2025 - 15:26
Lilly’s oral GLP-1 drug orforglipron met key goals in a Phase 3 trial, showing significant A1C and weight reductions in type 2 diabetes patients.
https://mexicobusiness.news/tag/weight-loss-0
More Health
By Sofía Garduño - Fri, 01/24/2025 - 14:16
A new study reveals GLP-1 drugs' cognitive benefits, including reduced addiction, but also highlights gastrointestinal and kidney issues.
By MBN Staff - Tue, 09/17/2024 - 17:12
Novo Nordisk's amycretin shows a 13.1% weight loss in early trials with mild side effects, potentially revolutionizing obesity treatment.
By MBN Staff - Thu, 07/11/2024 - 09:35
Only 25% of patients continue using Wegovy or Ozempic after two years, raising concerns about the cost-effectiveness of these expensive drugs.
By Anmol Motwani - Wed, 07/10/2024 - 09:51
Novo Nordisk’s semaglutide in Wegovy and Ozempic shows higher NAION risk. Prices are notably lower in Mexico compared to the US.
By MBN Staff - Fri, 05/24/2024 - 10:40
Research reveals specific genetic profiles could predict better responses to Novo Nordisk's weight-loss drug Wegovy among patients with obesity.
By Anmol Motwani - Tue, 03/26/2024 - 09:34
AHA study shows intermittent fasting may raise cardiovascular risks, sparking further research on its long-term effects.
By MBN Staff - Wed, 03/13/2024 - 10:00
Novo Nordisk's amycretin, set to launch within this decade, aims to contribute to the fight against the global obesity epidemic.
By Sofía Garduño - Wed, 03/06/2024 - 13:32
Experts from the ABC Medical Center emphasize the importance of maintaining long-term healthy habits in one's lifestyle for effective weight loss.
By MBN Staff - Tue, 02/13/2024 - 13:34
Findings suggest diabetes and weight-loss drugs may aid hip replacement patients, but cautious experts call for further research.
